Justin Bowers
Stock Analyst at Deutsche Bank
(1.75)
# 3,168
Out of 4,876 analysts
49
Total ratings
35.48%
Success rate
1.34%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $310 → $325 | $352.41 | -7.78% | 3 | Nov 4, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $157.47 | +68.29% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $4.98 | +361.85% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $21.15 | +37.12% | 1 | Aug 19, 2024 | |
| AMED Amedisys | Downgrades: Hold | $101 | $97.92 | +3.15% | 11 | Jul 31, 2024 | |
| MEDP Medpace Holdings | Maintains: Hold | $395 → $336 | $310.69 | +8.15% | 2 | Jul 24, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $11.73 | +113.13% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $123.56 | +25.45% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $408.28 | +49.41% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $51.84 | +58.18% | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $23 → $25 | $13.53 | +84.77% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $2.47 | +588.26% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $144.56 | +107.53% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $198.80 | +38.33% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $218.87 | +14.22% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $150.01 | +93.32% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $15.27 | +201.24% | 5 | May 10, 2021 |
Waters
Nov 4, 2024
Maintains: Hold
Price Target: $310 → $325
Current: $352.41
Upside: -7.78%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $157.47
Upside: +68.29%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $4.98
Upside: +361.85%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $21.15
Upside: +37.12%
Amedisys
Jul 31, 2024
Downgrades: Hold
Price Target: $101
Current: $97.92
Upside: +3.15%
Medpace Holdings
Jul 24, 2024
Maintains: Hold
Price Target: $395 → $336
Current: $310.69
Upside: +8.15%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $11.73
Upside: +113.13%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $123.56
Upside: +25.45%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $408.28
Upside: +49.41%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $51.84
Upside: +58.18%
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $13.53
Upside: +84.77%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $2.47
Upside: +588.26%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $144.56
Upside: +107.53%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $198.80
Upside: +38.33%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $218.87
Upside: +14.22%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $150.01
Upside: +93.32%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $15.27
Upside: +201.24%